Tag: targeted therapy

A Phase 1 trial found that combining the ATR inhibitor ceralasertib with the PARP inhibitor olaparib was generally well tolerated ...

Sylvester Comprehensive Cancer Center researchers report an FDA approval for a pancreatic cancer pill that nearly doubled survival, alongside new ...

A new review in Aging Cell positions endothelial TLR4 as a context-dependent molecular rheostat controlling vascular senescence, arguing that precision ...

UCLA oncologist Dr. Dennis Slamon has received the 2026 Albany Prize for discoveries that identified HER2-positive breast cancer and produced ...

A Dutch registry study finds the number of patients living long-term with de novo metastatic incurable cancer more than quadrupled ...

A new study finds the experimental cancer drug zavondemstat and the research compound QC6352 act mainly by blocking the enzyme ...

A multicenter real-world study of 465 patients found that adding brain radiotherapy to first-line third-generation EGFR inhibitors improved survival in ...

New research shows that CBP-driven histone H3K18 lactylation activates GLI2 transcription, promoting head and neck squamous cell carcinoma progression and ...

A new review in the Journal of Translational Medicine argues that c-MET signaling shapes spatially confined, metabolically driven immunosuppressive niches ...

A new review in Annals of Hematology details how molecular profiling and a growing arsenal of targeted and immune-based therapies ...

A new review in the Journal of Translational Medicine shows how combining molecular imaging, genomic profiling, and computational biology is ...

In a groundbreaking study that could change our understanding of gynecological health, researchers have delved into the genomic landscape of ...

In the realm of retinal research, a groundbreaking study has emerged that highlights the intricate relationship between IL-6 trans-signaling and ...

In a groundbreaking study published in “Military Medicine Research,” a team of researchers led by Xu et al. have unveiled ...

In the evolving landscape of oncology, prostate cancer continues to pose significant clinical challenges, spurring a relentless pursuit of advanced ...

Researchers at the University of California San Diego School of Medicine have announced a pioneering therapeutic strategy aimed specifically at ...

In a groundbreaking advancement in the fight against pancreatic and gastrointestinal cancers, researchers at the University of California, Riverside (UCR), ...

Recent studies have highlighted the complexities and challenges in treating germ cell tumors, particularly those that exhibit resistance to standard ...

Lung cancer remains a leading cause of cancer-related mortality worldwide, with various subtypes exhibiting unique molecular characteristics and treatment responses. ...

Breast cancer continues to be one of the most formidable challenges in oncology, claiming the lives of countless women and ...